A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
about
TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology.Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in miceThalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of InflammationTNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit.Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation.Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.N,N-Dimethylacetamide Significantly Attenuates LPS- and TNFα-Induced Proinflammatory Responses Via Inhibition of the Nuclear Factor Kappa B Pathway.Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles.Para-hydroxyphenylpyruvate inhibits the pro-inflammatory stimulation of macrophage preventing LPS-mediated nitro-oxidative unbalance and immunometabolic shift.Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities.
P2860
Q30410453-BA7A8180-AB07-4D4A-B08C-BA3CA0A5D6E1Q30520539-606F571A-989D-41D1-BEF2-D98CCC9C95C4Q35121026-68048804-4AD4-48D7-AC51-50B04234C0C4Q35818467-ACD45F89-E5B7-412E-9EF9-8FF5160F6AC9Q36118204-15DCBCF5-CA36-4DF2-81A2-ECEE18569E2CQ36169690-C6E0A007-A9E6-48DF-8A5F-521AFA0F3574Q36330960-94CF46BF-5CF0-41A7-BB77-F31BDFD8E8F3Q36727898-8DE22252-BF27-4B05-A5C0-65F4CE41730FQ37535101-434C0F49-8B11-473E-9485-6D16042FBF08Q37541052-7A820952-67E4-4BFA-8F09-DB6797D4DD12Q43230806-C8FCCB1D-9FF4-47A7-AE21-2F0A5FE7319AQ46254007-2CB94736-4A65-454F-8FB6-71A52E2D0B7DQ51767824-06621AAC-056A-4C30-9616-40DDB54CF830
P2860
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
@en
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
@nl
type
label
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
@en
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
@nl
prefLabel
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
@en
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
@nl
P2093
P2860
P1476
A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.
@en
P2093
Arnold Brossi
David Tweedie
Harold W Holloway
Nigel H Greig
Qian-sheng Yu
Ryan G Short
Weiming Luo
P2860
P304
P356
10.1016/J.JNEUMETH.2009.06.034
P577
2009-07-05T00:00:00Z